Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)

NCT00061646 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
25
Enrollment
INDUSTRY
Sponsor class

Stopped Enrollment suspended based upon interim analysis; subjects allowed to stay on study until disease progression.

Conditions

Interventions

Sponsor

Abbott